Pericardial Effusion Secondary to Nilotinib in an Elderly Patient With Chronic Myelogenous Leukemia

Tyrosine kinase inhibitors (TKIs) are the first-line treatment for patients with chronic myelogenous leukemia (CML). Serositis, including pleural and pericardial effusions, is a frequent adverse event with some TKIs while less frequent with others. We present a case of a 76-year-old woman with CML o...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Geetika, Adinugraha, Paulus, Aijaz, Amna, Vargas Pelaez, Alvaro, Rachko, Maurice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072281/
https://www.ncbi.nlm.nih.gov/pubmed/35530911
http://dx.doi.org/10.7759/cureus.23855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072281/
https://www.ncbi.nlm.nih.gov/pubmed/35530911
http://dx.doi.org/10.7759/cureus.23855

Ejemplares similares